Table II.
Three endpoints in two mouse groups.
Group | DT, days |
TGD, days |
ln SF | %SF | %KF | |
---|---|---|---|---|---|---|
Untreated/ Control |
|
0 | 0 | 100% | 0% | |
SE | 0.026 | 0 | ||||
PDT treated |
|
4.7 | −2.19 | 11.2% | 88.8% | |
SE | 0.26 | 0.19 | 0.096 | 1.1% | 1.1% |
Three endpoints in two mouse groups.
Group | DT, days |
TGD, days |
ln SF | %SF | %KF | |
---|---|---|---|---|---|---|
Untreated/ Control |
|
0 | 0 | 100% | 0% | |
SE | 0.026 | 0 | ||||
PDT treated |
|
4.7 | −2.19 | 11.2% | 88.8% | |
SE | 0.26 | 0.19 | 0.096 | 1.1% | 1.1% |